title: Narcolepsy as an initial manifestation of neuromyelitis optica with anti-aquaporin-4 antibody.
authors.forename: Toru
authors.initials: T
authors.lastname: Baba
authors.forename: Ichiro
authors.initials: I
authors.lastname: Nakashima
authors.forename: Takashi
authors.initials: T
authors.lastname: Kanbayashi
authors.forename: Masatoshi
authors.initials: M
authors.lastname: Konno
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Takahashi
authors.forename: Kazuo
authors.initials: K
authors.lastname: Fujihara
authors.forename: Tatsuro
authors.initials: T
authors.lastname: Misu
authors.forename: Atsushi
authors.initials: A
authors.lastname: Takeda
authors.forename: Yusei
authors.initials: Y
authors.lastname: Shiga
authors.forename: Hiromasa
authors.initials: H
authors.lastname: Ogawa
authors.forename: Yasuto
authors.initials: Y
authors.lastname: Itoyama
mesh_terms: D000328:Adult; D051401:Aquaporin 4 / Q000276:immunology*; D001323:Autoantibodies / Q000032:analysis / Q000097:blood*; D015415:Biomarkers / Q000032:analysis / Q000097:blood; D018450:Disease Progression; D005260:Female; D006801:Humans; D007031:Hypothalamus / Q000473:pathology / Q000503:physiopathology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D047908:Intracellular Signaling Peptides and Proteins / Q000032:analysis / Q000134:cerebrospinal fluid; D008279:Magnetic Resonance Imaging; D008636:Mesencephalon / Q000473:pathology / Q000503:physiopathology; D008775:Methylprednisolone / Q000627:therapeutic use; D009290:Narcolepsy / Q000276:immunology* / Q000473:pathology / Q000503:physiopathology*; D009471:Neuromyelitis Optica / Q000150:complications* / Q000276:immunology* / Q000473:pathology; D009479:Neuropeptides / Q000032:analysis / Q000134:cerebrospinal fluid; D015835:Ocular Motility Disorders / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D000068797:Orexins; D017286:Polysomnography; D011237:Predictive Value of Tests; D012008:Recurrence; D013116:Spinal Cord / Q000473:pathology / Q000503:physiopathology; D016896:Treatment Outcome
chemical_list: C496030:AQP4 protein, human; D051401:Aquaporin 4; D001323:Autoantibodies; D015415:Biomarkers; D007166:Immunosuppressive Agents; D047908:Intracellular Signaling Peptides and Proteins; D009479:Neuropeptides; D000068797:Orexins; D008775:Methylprednisolone